|Bid||5,750.00 x 0|
|Ask||5,770.00 x 0|
|Day's Range||5,720.00 - 5,840.00|
|52 Week Range||3,180.00 - 6,260.00|
|Beta (5Y Monthly)||0.67|
|PE Ratio (TTM)||18.47|
|Earnings Date||Jan 29, 2021|
|Forward Dividend & Yield||80.00 (1.38%)|
|Ex-Dividend Date||Mar 30, 2021|
|1y Target Est||3,210.00|
NEC Corporation (NEC; TOKYO: 6701) today announced the development of "WISE VISION Endoscopy," an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan today and is expected to soon be available in Europe. This software connects with existing endoscopy equipment as part of using AI to automatically mark potential lesions from images taken during endoscopic procedures.
Rating Action: Moody's withdraws ratings of WP/AV CH Holdings II B.V. Frankfurt am Main, December 30, 2020 -- Moody's Investors Service ("Moody's") has today withdrawn the B2 corporate family rating (CFR) and the B2-PD probability of default rating (PDR) of WP/AV CH Holdings II B.V. (Avaloq), the top entity in Avaloq's restricted group. Concurrently, Moody's has withdrawn the B2 rating on the CHF 350 million senior secured term loan B and the CHF 60 million senior secured revolving credit facility (RCF), both borrowed by WP/AV CH Holdings III B.V. At the time of the withdrawal, the ratings were placed on review for upgrade.
Avaloq’s acquisition by NEC successfully completed